Medication overuse headache

S Ashina, GM Terwindt, TJ Steiner, MJ Lee… - Nature Reviews …, 2023 - nature.com
Medication overuse headache (MOH) is a secondary headache disorder attributed to
overuse of acute headache medications by a person with an underlying headache disorder …

[HTML][HTML] Questionnaire-based survey during COVID-19 vaccination on the prevalence of elderly's migraine, chronic daily headache, and medication-overuse …

M Katsuki, J Kawahara, Y Matsumori… - Journal of clinical …, 2022 - mdpi.com
Background: The prevalence of headache disorders, migraine, chronic daily headache
(CDH), and medication-overuse headache (MOH) among the elderly in Japan has not been …

[HTML][HTML] Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials

C Lampl, V Kraus, K Lehner, B Loop… - The Journal of …, 2022 - Springer
Background Erenumab, a fully human monoclonal antibody that targets the calcitonin gene-
related peptide receptor, has demonstrated efficacy and safety in the prevention of episodic …

[HTML][HTML] Cluster headache: an update on clinical features, epidemiology, pathophysiology, diagnosis, and treatment

D San-Juan, K Velez-Jimenez, J Hoffmann… - Frontiers in Pain …, 2024 - frontiersin.org
Cluster headache (CH) is one of the worst primary headaches that remain underdiagnosed
and inappropriately treated. There are recent advances in the understanding of this disease …

[HTML][HTML] Developing an artificial intelligence-based pediatric and adolescent migraine diagnostic model

S Sasaki, M Katsuki, J Kawahara, C Yamagishi, A Koh… - Cureus, 2023 - ncbi.nlm.nih.gov
Methods The AI-based headache diagnosis model was created based on the internal
validation based on a retrospective investigation of 909 patients (636 training dataset for …

Headache Education by E-Learning Through Social Networking Services (Social Media)

M Katsuki, M Nanri, Y Miyakoshi, S Gobo… - Journal of Healthcare …, 2023 - Taylor & Francis
Introduction Headache is a common public health problem, but its burden could be avoided
by raising headache awareness and the appropriate use of acute medication and …

[HTML][HTML] Migraine and Tension-type Headache in Parkinson's Disease and Progressive Supranuclear Palsy/Corticobasal Syndrome

V Jatale, A Tiwari, M Kumar, R Gupta… - Annals of Indian …, 2023 - journals.lww.com
Objective: To compare the prevalence and characteristics of migraine and tension-type
headache (TTH) among patients with Parkinson's disease (PD), progressive supranuclear …

[PDF][PDF] Headache Medicine

H Ramadan - Headache, 2024 - pdfs.semanticscholar.org
Methods This bibliometric analysis analyzed the trending publications about hypertension
and migraine. The Scopus database was used, and the bibliometric analysis was applied to …

Analyzing the predictors of relapse in drug-induced headache: a prospective clinical and psychological study

EA Guziy, AV Sergeev… - Neurology …, 2024 - nnp.ima-press.net
The prevalence of drug-induced headache (DIHA) in the population is about 7%, and the
relapse rate of DIHA after successful treatment is about 40% within 5 years. Objective: to …

[PDF][PDF] Chinese Herbal Medicine Therapies for Migraine: Current State of Evidence, Impact on Practice, and a Real-world Setting Evaluation

S Lyu - 2023 - researchrepository.rmit.edu.au
Chinese Herbal Medicine Therapies for Migraine: Current State of Evidence, Impact on
Practice, and a Real-world Setting Evaluati Page 1 Chinese Herbal Medicine Therapies for …